Keyphrases
Adjuvant Endocrine Therapy
100%
Breast Cancer Recurrence
100%
Breast Cancer Mortality
100%
Breast Cancer
66%
Women with Breast Cancer
66%
Low Adherence
66%
Aromatase Inhibitors
66%
Scotland
33%
Tayside
33%
All-cause Mortality
33%
Cancer Mortality
33%
Risk of Death
33%
Retrospective Cohort Study
33%
Death Records
33%
Hospital Discharge Records
33%
Cancer Registry
33%
In-hospital Death
33%
Survival Analysis
33%
Adjuvant Tamoxifen
33%
Cancer Recurrence
33%
Estrogen Receptor-positive Breast Cancer
33%
Cancer Audit
33%
Nursing and Health Professions
Breast Cancer
100%
Cohort Analysis
100%
Cancer Mortality
100%
Hormonal Therapy
100%
Tamoxifen
40%
Aromatase Inhibitor
40%
Malignant Neoplasm
20%
Clinical Audit
20%
Hospital Discharge
20%
All Cause Mortality
20%
Cancer Registry
20%
Survival Analysis
20%
Cancer Recurrence
20%
Estrogen Receptor Positive Breast Cancer
20%
Medicine and Dentistry
Breast Cancer
100%
Cohort Analysis
100%
Cancer Mortality
100%
Adjuvant Endocrine Therapy
100%
Tamoxifen
40%
Aromatase Inhibitor
40%
Malignant Neoplasm
20%
Retrospective Cohort Study
20%
All Cause Mortality
20%
Cancer Registry
20%
Survival Analysis
20%
Estrogen Receptor Positive Breast Cancer
20%
Cancer Recurrence
20%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Cohort Study
100%
Cancer Mortality
100%
Endocrine Therapy
100%
Tamoxifen
40%
Aromatase Inhibitor
40%
Malignant Neoplasm
20%
All Cause Mortality
20%
Cancer Registry
20%
Estrogen Receptor Positive Breast Cancer
20%
Cancer Recurrence
20%